Back

Fate Therapeutics Quote, Financials, Valuation and Earnings

BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty

Click here now to prepare yourself for what's around the corner

Sell

FATE
Fate Therapeutics

Last Price:

5.04

Seasonality Move:

6.08%

7 Day Trial

ALL ACCESS PASS

$ 7

NOW is the time to get in on this trillion-dollar megatrend

Get it here.

Fate Therapeutics Price Quote

$5.04

-0.23 (-4.36%)

(Updated: April 18, 2024 at 6:55 PM ET)

Fate Therapeutics Key Stats

Sell

Fate Therapeutics (FATE) is a Sell

Day range:

$5.21 - $5.63

52-week range:

$1.63 - $8.83

Dividend yield:

P/E ratio:

0.00

P/S ratio:

8.17

P/B ratio:

1.42%

Volume:

1.8M

Avg. volume:

2.5M

1-year change:

-20.03%

Market cap:

$523.5M

Revenue:

$63.5M

EPS:

$-1.64

How Much Does Fate Therapeutics Make?

How Much Are Fate Therapeutics's Sales Annually?
FATE Revenues are $63.5M
How Much Profit Does Fate Therapeutics's Make A Year?
FATE net income is -$160.9M

Is Fate Therapeutics Growing As A Company?

What Is Fate Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.96%
What Is Fate Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Fate Therapeutics Stock Price Performance

Did Fate Therapeutics Stock Go Up Last Month?
Fate Therapeutics share price went down by -29.64% last month
Did FATE's Share Price Rise Over The Last Year?
FATE share price fell by -20.03% over the past 1 year

What Is Fate Therapeutics 52-Week High & Low?

What Is Fate Therapeutics’s 52-Week High Share Price?
Fate Therapeutics has traded as high as $8.83 over the past 52 weeks
What Is Fate Therapeutics’s 52-Week Low Share Price?
Fate Therapeutics has traded as low as $1.63 over the past 52 weeks

Fate Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Fate Therapeutics?

How Much Debt Does Fate Therapeutics Have?
Total long term debt quarterly is $0
How Much Cash Does Fate Therapeutics Have?
Cash and short term investments quarterly total is $315.2M
What Is Fate Therapeutics’s Book Value Per Share?
Book value per share is 3.74

Is Fate Therapeutics Cash Flow Positive?

What Is FATE Cash Flow From Operations?
Cash flow from operations (TTM) is -$132.3M
What Is Fate Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $85K
What Is Fate Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $112.7M

Fate Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
FATE return on invested capital is -37.07%
What Is Fate Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -27.09%
What Is FATE Return On Equity?
ROE is a measure of profitability and is -37.07%

Fate Therapeutics Earnings Date & Stock Price

What Is Fate Therapeutics's Stock Price Today?
A single share of FATE can be purchased today for 5.27
What Is Fate Therapeutics’s Stock Symbol?
Fate Therapeutics trades on the nasdaq under the ticker symbol: FATE
When Is Fate Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Fate Therapeutics is scheduled on May 3, 2024
When Is FATE's next ex-dividend date?
Fate Therapeutics's next ex-dividend date is April 30, 2020
How To Buy Fate Therapeutics Stock?
You can buy Fate Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Fate Therapeutics Competitors

Who Are Fate Therapeutics's Competitors?
Below is a list of companies who compete with Fate Therapeutics or are related in some way:
- ADMA Biologics Inc (ADMA)
- Amicus Therapeutics Inc (FOLD)
- Ocular Therapeutix Inc (OCUL)
- Regeneron Pharmaceuticals Inc (REGN)
- Sarepta Therapeutics Inc (SRPT)

Fate Therapeutics Dividend Yield